Search
Toggle theme
Menu
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis | NobleBlocks
Back
Home
Publications
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Public
More options
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
N
Shared by
NobleBlocks
on Mar 23, 2023 • 12:00 AM UTC
Authors:
Jonathan I. Silverberg
,
Emma Guttman-Yassky
,
Diamant Thaçi
+9 more
Download PDF
Share
Summary
Sum
PDF
Figures
Figs
Discrepancies
Disc
EDDII
Article
Art
Finding related papers...
Discussions
(0)
Add Comment
No comments yet
Be the first to share your thoughts!
